ANI Pharmaceuticals reported $146.48M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
AbbVie USD 4.95B 13M Dec/2025
ANI Pharmaceuticals USD 146.48M 8.16M Sep/2025
Assertio Holdings USD 24.76M 8.12M Sep/2025
Aurora Cannabis CAD 221.96M 6.3M Sep/2025
Canopy Growth CAD 102.37M 8.55M Sep/2025
Eli Lilly USD 13.74B 1.56B Dec/2025
Emergent BioSolutions USD 328.9M 25.2M Dec/2023
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Hikma Pharmaceutical USD 1.08B 96M Jun/2025
Knight Therapeutics CAD 95.4M 2.91M Mar/2024
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Novartis USD 6.42B 114M Sep/2025
Omeros USD 712K 266K Sep/2021
Perrigo USD 1.23B 11.5M Sep/2025
Sun Pharmaceuticals INR 102.43B 3.08B Mar/2025
Teva Pharmaceutical Industries USD 3.18B 144M Dec/2025